7:45-8:45 a.m.
Becoming Involved in the AHA at the Affiliate/Local Levels

Moderators:
Lynne Braun, Chicago, Ill.
Lorraine Frazier, Houston, Texas

Presentations:
Capacity of the Affiliates to Use Volunteers: Perspective of an Executive Vice President
Kevin Harker, Overland Park, Kan.

Getting Involved with AHA at the Local Level: Why Volunteer? What Will it Do for Me?
Suzanne Hughes, Ravenna, Ohio

Volunteering in Local Initiatives: Making a Difference
Tamilyn Bakas, Indianapolis, Ind.

Volunteering at the Affiliative Level: Making a Difference
Annabelle Volgman, Chicago, Ill.

7:45-8:45 a.m.
Growing Up wtih Congenital Heart Disease: Challenges of Adolescents

Moderator:
Elizabeth Tong, San Francisco, Calif.

Presentations:
Developmental Needs and Psychosocial Issues
Angela Green, Little Rock, Ark.

Sexual Health
Kiersten Wells, Palo Alto, Calif.

Noncompliance and Other Risky Behaviors
Adrienne Kovacs, Toronto, Ontario, Canada

7:45-8:45 a.m.
Managing Elevated Glucose in Patients Hospitalized with ACS

Moderator:
Silvio Inzucchi, New Haven, Conn.

Invited Presenters:
Darren K. McGuire, Dallas, Texas
Mikhail Kosiborod, Kansas City, Mo.
Eleanor Fitzpatrick, Philadelphia, Pa.

7:45-8:45 a.m.
How to Improve Cardiovascular Practice through Practice-Based Evidence

Moderator:
Nancy Albert, Cleveland, Ohio

Presentations:
What is Practice-Based Evidence for Cardiovascular Clinical Practice?
TBD

Practice-Based Evidence Designs vs. Randomized Controlled Trials
David Hellerstein, New York, N.Y.

How to Improve Cardiovascular Clinical Practice through Practice-Based Evidence
TBD

7:45-8:45 a.m.
How to Manage the Obese Patient (Clinical Tips)

Moderator: Marian Limacher, Gainesville, Fla

Invited Presenters:
Jean-Pierre Despres, Quebec City, QC, Canada
Lora Burke, Pittsburgh, Pa.
Arya Sharma, Edmonton, AB, Canada

9-10:15 a.m.
Addressing Palliative and End of Life Care with Cardiac Patients

Moderator: TBD

Presentations:
Breaking Bad News
TBD

Palliative Care: Non-pharmacological Interventions to Improve Symptoms
TBD

Integration of Palliative Care into Heart Failure Management Programs
Cheryl H. Zambroski, Tampa, Fla.

Palliative Care: Pharmacological Agents to Prevent and Manage Symptoms
Suzanne J. Wingate, Gaithersburg, Md.

12-2 p.m.
Pediatric Nursing Research Networking Luncheon: The Devil is in the Details
Panel: Liz Tong, Karen Uzark, Angela Green, and Kathy Mussatto

3:45-5 p.m.
Percutaneous, Surgical and Medical Management of Hypertrophic Obstructive Cardiomyopathy

Moderators:
Ulrich Sigwart, Geneva, Switzerland
Glen S. Van Arsdell, Toronto, Ontario, Canada

Presentations:
The Genetics of Hypertrophic Obstructive Cardiomyopathy
Christine E. Seidman, Boston, Mass.

Physiology and Medical Management
Mark Sherrid, New York, N.Y.

Risk Stratification and Treatment of Sudden Cardiac Death
William J. McKenna, London, United Kingdom

Percutaneous Septal Ablation
William H. Spencer, Charleston, S.C.

Septal Myectomy and Mitral Valve Surgery
Nicholas Smedira, Cleveland, Ohio

3:45-5 p.m.
Improvement in Treatment Options for PCI Patients with ACS

Moderators:
Philip Aylward, Adelaide, Australia
Judith Hochman, New York, N.Y.

Presentations:
What's New in our Understanding of Platelet Biology: Receptors, Genotypes and Resistance
Lisa K. Jennings, Memphis, Tenn.

Advances in Thienopyridines: New Data with Clopidogrel and Prasurgrel
Stephen D. Wiviott, Boston, Mass.

The Arrival of The First Oral Non-Thienopyridine ADP Blockers
Stefan K. James, Uppsala, Sweden

Benefits and Challenges with Intravenous Antiplatelet Agents: EARLY, CHAMPION and INNOVATE
Harvey White, Auckland, New Zealand

Beyond ADP Blockade: What's Next in Antiplatelet Therapy
Kenneth W Mahaffey, Durham, N.C.

5:30-6:45 p.m.
Can We Stem the Tide of Increasing Cardiovascular Risk?

Moderator:
Erika Sivarajan Froelicher, San Francisco, Calif.

Presentations:
What Does a Life-Course Approach Offer?
Lynne Braun, Chicago, Ill.

How Do We Manage High-Risk Children?
Laura L. Hayman, Boston, Mass.

Are Community/Public Health Interventions Effective?
Catriona S. Jennings, London, United Kingdom

Finding the Balance Between the 'Nanny State' and Personal Freedoms
Christi Deaton, Manchester, United Kingdom

Macro-Level Interventions: The European Heart Health Charter
Tone M. Norekval, Bergen, Norway

5:30-6:45 p.m.
Fetal Cardiology: The Present and the Future

Moderators:
Patricia O'Brien, Boston, Mass.
James Huhta, St. Petersburg, Fla.

Presentations:
Current Status of Fetal Diagnosis of CHD: How Accurate Are We?
Gurleen Sharland, London, United Kingdom

Three-Dimensional Imaging of the Fetal Heart
John Simpson, London, United Kingdom

Outcomes of Fetal Diagnosis of Complex Defects
Wayne Tworetzky, Boston, Mass.

Counseling the Parents of an Affected Fetus
Gwen Rempel, Edmonton, AB, Canada

5:30-6:45 p.m.
Recent Clinical Trials in Ischemic Heart Disease: A Multidisciplinary Discussion of Implications for Practice

Moderators:
Mariell Jessup, Philadelphia, Pa.
Elliott Antman, Boston, Mass.

Presentations:
STICH Trial Presentation
Robert H. Jones, Durham, N.C.

Surgical Perspective
Robert A. Guyton, Atlanta, Ga.

HF Perspective
Sharon Hunt, Palo Alto, Calif.

General Cardiology Perspective
Eugene Braunwald, Boston, Mass.

BARI 2D Trial Presentation
Robert L. Frye, Rochester, Minn.

Diabetes Perspective
Allison Goldfine, Boston, Mass.

General Cardiology Perspective
Valentin Fuster, New York, N.Y.

5:30-6:45 p.m.
Stroke Prevention in Atrial Fibrillation - 2009

Moderator:
Richard Page, Seattle, Wash.

Presentations:
Understanding the Coagulation Cascade
Charles T. Esmon, Oklahoma City, Okla.

Thrombin Inhibitors in 2009
Michael D. Ezekowitz, Wynnewood, Pa.

Is Warfarin Obsolete?
Gregory Lip, England, United Kingdom

Antiplatelet Drugs - Do They Have A Role?
Jonathan L Halperin, New York, N.Y.

Status of Factor Xa Inhibitors
Lars Wallentin, Uppsala, Sweden

5:30-6:45 p.m.
Type 2 Diabetes: Long Term Glucose Control in 2009 – What Are The Strategies?

Moderator:
Theodore Mazzone, Chicago, Ill.

Presentations:
Glucose Control and Its Implications for Macrovascular Endpoints - VA Diabetes Trial Perspective
Carlos Abraira, Miami, Fla.

Impact of Glucose Control on Macro and Microvascular Disease: Insights from ADVANCE
Anushka Patel, Sydney, Australia

Glucose Lowering in Type 2 Diabetes: Are All Strategies Equivalent?
Steven E. Nissen, Cleveland, Ohio